| Patent | Date |
|---|
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
Grant 10,183,001 - King , et al. Ja | 2019-01-22 |
Safety of pseudoephedrine drug products
Grant 9,421,266 - King , et al. August 23, 2 | 2016-08-23 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 9,226,925 - King , et al. January 5, 2 | 2016-01-05 |
Opioid Salts with Release Properties and Characteristics Useful for Abuse Deterrent Drug Product Formulations
App 20150164835 - King; Clifford Riley ; et al. | 2015-06-18 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,980,880 - King , et al. March 17, 2 | 2015-03-17 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,957,067 - King , et al. February 17, 2 | 2015-02-17 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,940,729 - King , et al. January 27, 2 | 2015-01-27 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 8,921,386 - King , et al. December 30, 2 | 2014-12-30 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 08921386 - | 2014-12-30 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,916,587 - King , et al. December 23, 2 | 2014-12-23 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,912,217 - King , et al. December 16, 2 | 2014-12-16 |
Safety of psuedoephedrine drug products
Grant 8,883,863 - King , et al. November 11, 2 | 2014-11-11 |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
Grant 8,859,622 - Bristol , et al. October 14, 2 | 2014-10-14 |
Abuse-deterrent methadone for the safe treatment of drug abuse and pain relief
Grant 8,846,766 - King , et al. September 30, 2 | 2014-09-30 |
Safety Of Psuedoephedrine Drug Products
App 20140178480 - King; Clifford Riley ; et al. | 2014-06-26 |
Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
Grant 8,748,416 - King , et al. June 10, 2 | 2014-06-10 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,716,337 - King , et al. May 6, 2 | 2014-05-06 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,716,278 - King , et al. May 6, 2 | 2014-05-06 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,653,106 - King , et al. February 18, 2 | 2014-02-18 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,653,065 - King , et al. February 18, 2 | 2014-02-18 |
Abuse-Deterrent Methadone for the Safe Treatment of Drug Abuse and Pain Relief
App 20130338229 - King; Clifford Riley ; et al. | 2013-12-19 |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Grant 8,586,575 - King , et al. November 19, 2 | 2013-11-19 |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
Grant 8,575,151 - Bristol , et al. November 5, 2 | 2013-11-05 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 8,569,329 - King , et al. October 29, 2 | 2013-10-29 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 8,569,330 - King , et al. October 29, 2 | 2013-10-29 |
Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
Grant 8,476,291 - King , et al. July 2, 2 | 2013-07-02 |
Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties
Grant 8,367,693 - King , et al. February 5, 2 | 2013-02-05 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 8,338,444 - King , et al. December 25, 2 | 2012-12-25 |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
Grant 8,334,322 - Bristol , et al. December 18, 2 | 2012-12-18 |
Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
Grant 8,329,720 - King , et al. December 11, 2 | 2012-12-11 |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Grant 8,211,905 - King , et al. July 3, 2 | 2012-07-03 |
Abuse Deterrent And Anti-dose Dumping Pharmaceutical Salts Useful For The Treatment Of Attention Deficit/hyperactivity Disorder
App 20120028960 - King; Clifford Riley ; et al. | 2012-02-02 |
Physical states of a pharmaceutical drug substance
Grant 8,039,461 - Audia , et al. October 18, 2 | 2011-10-18 |
Physical and chemical properties of thyroid hormone organic acid addition salts
Grant 7,858,663 - Bristol , et al. December 28, 2 | 2010-12-28 |
Physical states of a pharmaceutical drug substance
Grant 7,718,649 - King , et al. May 18, 2 | 2010-05-18 |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
App 20090259039 - Bristol; David William ; et al. | 2009-10-15 |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
App 20080293695 - Bristol; David William ; et al. | 2008-11-27 |
| 